A major research effort to develop medical products to diagnose, prevent
and treat the short- and long-term consequences of radiation exposure
after a radiological or nuclear terrorist attack has been renewed today
by the National Institute of Allergy and Infectious Diseases (NIAID),
part of the National Institutes of Health.
View full post on National Institutes of Health (NIH) News Releases